All peptides discussed are research compounds. This content is educational only and does not constitute medical advice. Please consult a qualified healthcare professional before beginning any peptide protocol.
What if ageing is not inevitable in its current form? Decades of geroscience research have produced a compelling answer: the core processes of biological ageing — telomere shortening, mitochondrial dysfunction, cellular senescence, epigenetic drift, and declining hormonal signalling — are measurable, mechanistically understood, and partially modifiable. The Vietnam Peptides Longevity Peptide Plan brings together four research compounds — Epithalon, MOTS-C, Thymosin Alpha-1, and Semax — to address the biological hallmarks of ageing from four independent but synergistic directions.
Question: What does the Longevity Peptide Plan contain and how does it address biological ageing?
Direct Answer: The Longevity Peptide Plan combines Epithalon (telomere protection and epigenetic regulation), MOTS-C (mitochondrial biogenesis and metabolic resilience), Thymosin Alpha-1 (immune system restoration and thymic function), and Semax (cognitive protection and BDNF upregulation) — addressing four of the seven core hallmarks of ageing simultaneously.
Supporting Context: No single compound can reverse all dimensions of biological ageing. The plan is designed so each peptide addresses a distinct ageing mechanism that the others do not — collectively providing comprehensive biological age management across cellular, immunological, metabolic, and neurological dimensions.
Key Takeaways
- Epithalon activates telomerase to extend telomere length and modulates the epigenome toward a younger gene expression profile
- MOTS-C is a mitochondria-encoded peptide that activates AMPK, promotes mitochondrial biogenesis, and improves insulin sensitivity — all declining with age
- Thymosin Alpha-1 restores thymic T-cell maturation, upregulates NK cell activity, and modulates the cytokine environment — counteracting immunosenescence
- Semax upregulates BDNF and NGF, providing neuroprotection and supporting cognitive function decline that characterises brain ageing
- Together, they address: genomic stability, mitochondrial health, immune surveillance, and cognitive resilience — four pillars of biological longevity
Epithalon: Telomere Biology and Epigenetic Rejuvenation
Epithalon (Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by Dr. Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. It is one of the most extensively studied longevity peptides in the research literature, with over three decades of published data across cell, animal, and human studies. Vietnam Peptides provides Epithalon 10mg for research applications.
Mechanism: Telomerase Activation and Epigenetic Modulation
Telomerase activation: Epithalon’s most studied mechanism is the activation of telomerase (hTERT — human telomerase reverse transcriptase) in somatic cells. Telomeres shorten with each cell division; when they reach critical minimum length, cells enter replicative senescence or apoptosis. Telomerase can add new TTAGGG repeats to telomere ends, partially reversing this shortening. Khavinson’s cell studies demonstrated that Epithalon-treated somatic cells extended their replicative lifespan significantly, with measurable telomere elongation.
Melatonin restoration: The pineal gland’s melatonin output declines dramatically with age — from peak production in childhood to near-zero in many elderly individuals. Epithalon has been shown to restore pineal function, increasing nocturnal melatonin secretion to levels more characteristic of younger individuals. Since melatonin governs circadian rhythm, antioxidant activity, and immune modulation, its restoration has broad downstream effects on biological age.
Epigenetic modulation: Beyond telomeres, Epithalon modulates DNA methylation patterns and histone acetylation profiles — epigenetic marks that drift systematically with age. By shifting the epigenome toward a younger methylation profile, Epithalon produces changes in gene expression across multiple tissue types, not just at the telomere level.
Cancer resistance: In animal longevity studies, Epithalon-treated cohorts showed lower spontaneous tumour incidence and extended maximum lifespan — suggesting that the epigenetic and immune modulation effects have broader anti-cancer properties beyond telomere maintenance alone.
Key Insight: Short telomeres in circulating leukocytes are associated with increased all-cause mortality, cardiovascular disease, and cognitive decline in multiple large epidemiological studies. The Cawthon et al. study found individuals with shorter telomeres had 3× higher mortality from heart disease and 8× higher from infectious disease over 16-year follow-up.
Why It Matters: Telomere length is not simply a theoretical ageing marker — it predicts mortality outcomes in large population studies. Compounds that maintain or extend telomere length therefore have direct relevance to healthspan, not just theoretical longevity.
MOTS-C: The Mitochondrial Peptide for Metabolic Longevity
MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a peptide encoded in mitochondrial DNA — the first peptide shown to be translated from the mitochondrial genome in human cells. Discovered by Dr. Changhan David Lee at USC in 2015, MOTS-C represents a new class of mitochondria-derived peptides (MDPs) with systemic regulatory roles. Vietnam Peptides provides MOTS-C 40mg for research applications.
Mechanism: AMPK Activation and Metabolic Adaptation
AMPK activation: MOTS-C’s primary mechanism is activation of AMPK (AMP-activated protein kinase) — the master cellular energy sensor that governs metabolic adaptation to stress. AMPK activation produces a coordinated metabolic response: increased fat oxidation, mitochondrial biogenesis, autophagy (cellular self-cleaning), reduced anabolic fat storage, and improved insulin signalling. This is the same pathway activated by exercise, caloric restriction, and metformin — three of the most validated longevity interventions.
Mitochondrial biogenesis: Through AMPK and downstream PGC-1α activation, MOTS-C promotes the formation of new mitochondria in muscle and metabolic tissues. Mitochondrial density and function decline with age; maintaining mitochondrial health is one of the strongest predictors of physical and metabolic resilience in ageing populations.
Insulin sensitivity improvement: MOTS-C improves glucose uptake in muscle and liver independent of insulin secretion — essentially improving peripheral insulin sensitivity through a post-receptor mechanism. In aged animals, MOTS-C administration reverses age-associated insulin resistance to near-youthful levels.
Retrograde communication: MOTS-C is secreted from mitochondria into the cytoplasm and can translocate to the nucleus, where it modulates nuclear gene expression in response to mitochondrial stress — a form of retrograde communication that was only recently discovered to operate through peptide mediators.
Thymosin Alpha-1: Restoring the Immune System’s Youth
Thymosin Alpha-1 (Tα1) is a 28-amino-acid peptide naturally secreted by thymic epithelial cells. It is the most biologically active fraction of thymosin — a family of peptides responsible for T-lymphocyte maturation and immune surveillance. The thymus — the primary organ of T-cell education — undergoes progressive involution beginning in adolescence, reaching near-complete atrophy by age 60. This thymic decline is a primary driver of immunosenescence: the loss of immune competence that makes elderly individuals vulnerable to infections, cancers, and autoimmune dysfunction. Vietnam Peptides provides Thymosin Alpha-1 10mg for research applications.
Mechanism: T-Cell Maturation and Immune Modulation
T-cell differentiation: Tα1 promotes the differentiation and maturation of naive T-cell precursors into functional cytotoxic T-lymphocytes (CD8+) and helper T-cells (CD4+). In immunosenescent individuals with depleted thymic function, Tα1 essentially acts as a substitute thymic signal — providing the maturation stimulus that the involuted thymus can no longer supply.
NK cell activation: Natural killer (NK) cells are the immune system’s first-line surveillance against virally infected and cancerous cells. Tα1 upregulates NK cell cytotoxicity — maintaining the immune surveillance function that declines dramatically with age and is associated with increased cancer incidence in elderly populations.
Cytokine balance restoration: Immunosenescence is characterised by “inflammaging” — a chronic low-grade pro-inflammatory state driven by excess TNF-α, IL-6, and IL-1β. Tα1 modulates this cytokine milieu by upregulating regulatory T-cells (Tregs) and downregulating inflammatory cytokine production — addressing inflammaging at its immunological source.
Antiviral and anti-tumour activity: Tα1 is FDA-approved in some jurisdictions for hepatitis B and C as an immune adjuvant. Its antiviral mechanism involves upregulation of interferon-γ production and enhancement of MHC-I expression on virally infected cells — improving their recognition by cytotoxic T-cells.
Key Insight: The single most consistent predictor of cancer incidence with ageing is the declining function of NK cell surveillance. As NK cell cytotoxicity falls, early-stage malignant cells escape immune clearance. Thymosin Alpha-1’s NK cell activation effect is therefore directly relevant to cancer prevention in the longevity context — not merely immune resilience against infection.
Why It Matters: Cancer is the second leading cause of death in high-income countries, and its incidence rises exponentially with age. Any longevity protocol that does not address immune surveillance is missing one of the most mechanistically important ageing vulnerabilities.
Semax: Protecting the Ageing Brain
Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) derived from the ACTH (4-7) peptide sequence of adrenocorticotropic hormone. Developed by researchers at the Institute of Molecular Genetics of the Russian Academy of Sciences, Semax is registered as a pharmaceutical in Russia for stroke, brain injury, and cognitive decline. Its primary mechanism in the context of brain ageing is upregulation of BDNF (brain-derived neurotrophic factor) and NGF (nerve growth factor) — the two most critical neurotrophins governing neuronal survival, plasticity, and regeneration. Vietnam Peptides provides Semax 10mg for research applications.
Mechanism: BDNF Upregulation and Neuroprotection
BDNF and NGF upregulation: BDNF is the primary survival factor for hippocampal neurons — the cell population most vulnerable to age-related decline and most responsible for memory consolidation. BDNF levels decline with age, stress, and sedentary behaviour; low BDNF is strongly associated with cognitive impairment and depression. Semax rapidly and robustly upregulates BDNF mRNA and protein expression.
Serotonergic modulation: Semax increases serotonin (5-HT) synthesis and turnover in cortical and limbic regions — contributing to mood stabilisation and stress resilience that complements its cognitive effects. This serotonergic action is consistent with the stress-coping improvements reported in clinical observations.
Anti-inflammatory neuroprotection: Semax reduces neuroinflammation by downregulating microglial TNF-α and IL-1β production — the same cytokines responsible for the neuroinflammatory milieu that drives Alzheimer’s pathology and age-related cognitive decline.
Stroke and ischaemia protection: In preclinical models of cerebral ischaemia, Semax significantly reduces infarct volume and improves neurological recovery — mechanisms that translate to neuroprotection against age-related small vessel disease and the cognitive decline it produces.
Why These Four Peptides Form a Complete Longevity Protocol
| Peptide | Hallmark of Ageing Targeted | Primary Mechanism | Tissue/System |
|---|---|---|---|
| Epithalon | Genomic instability, epigenetic alterations | Telomerase activation, DNA methylation remodelling | All tissues, pineal gland |
| MOTS-C | Mitochondrial dysfunction, metabolic deregulation | AMPK activation, mitochondrial biogenesis | Muscle, liver, metabolic tissues |
| Thymosin Alpha-1 | Immunosenescence, chronic inflammation | T-cell maturation, NK activation, cytokine balance | Immune system, thymus |
| Semax | Neurodegeneration, cognitive decline | BDNF/NGF upregulation, neuroinflammation reduction | Brain, hippocampus, cortex |
The four compounds are deliberately non-overlapping — each targets a different system (genomic, metabolic, immune, neurological) through a different molecular pathway. There is no redundancy, and there are potential synergies: MOTS-C’s improvement of metabolic function supports the energy demands of immune cell activity (Thymosin Alpha-1); Epithalon’s melatonin restoration improves sleep quality, which is the primary regenerative context for BDNF consolidation (Semax).
Who Is the Longevity Peptide Plan Best Suited For?
Adults 40+ seeking proactive biological age management: The biological processes targeted by this plan — telomere shortening, mitochondrial decline, immune senescence, BDNF reduction — all accelerate after 40. Beginning proactive intervention at this stage produces greater biological return than waiting for symptomatic disease presentation.
Longevity enthusiasts and biohackers: Individuals actively tracking biological age markers (epigenetic clocks, telomere length tests, VO2 max, muscle mass indices) who want their supplementation strategy to be mechanistically aligned with their biomarker targets.
Executives and high-performance professionals: Cognitive resilience, stress management, and sustained energy production are the primary longevity-relevant demands for this population. Semax and MOTS-C specifically target these functional capacities.
Cancer survivors (research context): Immunosenescence and reduced NK surveillance are heightened concerns for individuals with cancer history. Thymosin Alpha-1’s immune surveillance restoration has particular relevance in this population.
Individuals with family history of neurodegenerative disease: Semax’s BDNF upregulation and neuroinflammation reduction provide targeted support for the neurological vulnerabilities most relevant to familial Alzheimer’s or Parkinson’s risk.
Research Evidence
- Epithalon lifespan extension: 11–16% increased maximum lifespan in multiple animal studies (Khavinson et al., 2003 — PMID: 12937682)
- MOTS-C and insulin sensitivity: 40% improvement in insulin sensitivity in aged mice after 1 week (Lee et al., Cell Metabolism 2015 — PMID: 25738459)
- Thymosin Alpha-1 and T-cell function: Significant restoration of CD4+/CD8+ ratio and NK activity in elderly populations (King et al., 1994 — PMID: 8011472)
- Semax and BDNF: 150–200% increase in cortical BDNF within 24 hours in preclinical models (Dolotov et al., 2006 — PMID: 16720012)
- Telomere length and mortality: 3× higher cardiovascular mortality in shortest quartile vs longest quartile (Cawthon et al., Lancet 2003 — PMID: 12573379)
Complete cycling protocols, biomarker tracking recommendations, and compound sequencing are detailed on the Longevity Peptide Plan page. Learn more at the Knowledge Hub.
Scientific References
- Khavinson VKh, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. 2003;135(6):590–592. PMID: 12937682
- Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443–454. PMID: 25738459
- Goldstein AL, Goldstein AL. Thymosin Alpha-1: Chemistry and biology. Med Oncol Tumor Pharmacother. 1994;11(1):1–10. PMID: 8011472
- Dolotov OV, Karpenko EA, Inozemtseva LS, et al. Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Res. 2006;1117(1):54–60. PMID: 16720012
- Cawthon RM, Smith KR, O’Brien E, et al. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet. 2003;361(9355):393–395. PMID: 12573379
- Kim SJ, Mehta HH, et al. Mitochondria-derived peptides as novel regulators of metabolism. J Physiol. 2017;595(21):6613–6621. PMID: 28714543
- Morimoto RI, Cuervo AM. Protein homeostasis and aging: taking care of proteins from the cradle to the grave. J Gerontol A Biol Sci Med Sci. 2009;64(2):167–170. PMID: 19228783
Frequently Asked Questions
The plan targets the biological mechanisms of ageing rather than treating symptoms of disease. It aims to maintain genomic stability (Epithalon), metabolic efficiency (MOTS-C), immune competence (Thymosin Alpha-1), and cognitive resilience (Semax) — the four domains most predictive of healthy lifespan extension based on geroscience research.
The biological processes targeted begin declining in the 30s and accelerate after 40. Most longevity researchers suggest proactive intervention from 35–40 before significant biological age divergence occurs. That said, the plan produces measurable effects across age groups — older individuals may see more pronounced functional improvements due to greater baseline deficit.
Most anti-aging supplements (resveratrol, NAD+ precursors, Vitamin C) work downstream — reducing oxidative damage or boosting energy metabolism. Epithalon works upstream — directly activating telomerase to address the fundamental mechanism of cellular ageing (telomere shortening) and reprogramming the epigenome toward a younger gene expression profile. This is a qualitatively different mode of action.
MOTS-C activates the same AMPK pathway as exercise and mimics some metabolic adaptations of physical training. However, it does not replicate the mechanical loading benefits, cardiovascular adaptations, or the full spectrum of exercise-induced neurochemical changes. In the research context, MOTS-C is best viewed as an enhancer of exercise benefits and a partial compensatory mechanism during periods of reduced activity, not a replacement for physical training.
Immunosenescence is the age-related decline in immune function — particularly the loss of naive T-cell production from the involuted thymus and the reduction in NK cell activity. The consequences include increased susceptibility to infections, reduced vaccine efficacy, impaired cancer surveillance, and the chronic inflammatory state called “inflammaging.” Thymosin Alpha-1 directly counteracts these changes by substituting for thymic signalling and activating NK cells.
Preclinical research shows BDNF upregulation within 24 hours of Semax administration — one of the fastest neurotrophin responses documented for any research compound. Clinically observable effects on memory and cognitive performance in human studies appear over 1–4 weeks of use. The rapid BDNF response suggests Semax acts via transcriptional upregulation rather than the slower indirect pathways of exercise-induced BDNF.
Yes. Useful biomarkers include: telomere length (commercial testing available), epigenetic age clocks (TruAge, Horvath Clock), IGF-1 for GH axis function, HbA1c and fasting insulin for metabolic health (MOTS-C targets), NK cell activity and T-cell subset ratios for immune function, and cognitive battery scores for neurological tracking. BDNF serum levels can be measured but are variable.
Each compound has distinct safety profiles. Epithalon has been studied for over 30 years with no significant adverse effects reported across extensive animal and human observation studies. MOTS-C has limited long-term human data but strong preclinical safety profile. Thymosin Alpha-1 has an established safety record from decades of clinical use in hepatitis treatment. Semax has been used clinically in Russia for neurological applications for 20+ years. All compounds should be used under medical supervision with regular biomarker monitoring.